Skip to main content
Erschienen in: Neurological Sciences 3/2021

29.10.2020 | Original Article

Prevalence, risk factors, and clinical correlations of underweight in Chinese newly diagnosed and drug-naïve patients with Parkinson’s disease

verfasst von: Qing Wu, Ming Yu, Jianfei Fu, Meizhen Liu

Erschienen in: Neurological Sciences | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

Studies have shown that patients with Parkinson’s disease (PD) will experience weight loss during the progression of the illness, which suggests an increased rate of underweight. However, few studies have addressed underweight in early de novo population. This study aimed to examine the prevalence, risk factors, and clinical correlations of underweight in Chinese newly diagnosed and drug-naïve patients with PD.

Methods

A total of 245 inpatients with newly diagnosed PD and 213 age-, sex-, and education-matched healthy controls were enrolled in Ningbo. BMI, demographics, supine and upright blood pressure, Montreal Cognitive Assessment (MoCA), Hamilton Anxiety Scale (HAMA), Hamilton Depression Scale (HAMD) together with fasting blood glucose, low-density lipoprotein, total cholesterol, uric acid (UA), and homocysteine were collected in all subjects. Hoehn and Yahr (HY) rating and Unified Parkinson’s Disease Rating Scale (UPDRS) motor scores were also measured in patients.

Results

Overall, 35 (14.3%) patients were underweight and 14 (6.6%) controls were underweight. Binary regression analyses showed that low MoCA (p = 0.035), ΔSBP and ΔDBP values (both p < 0.001) were risk factors for underweight. Furthermore, correlation analysis indicated that BMI was associated with HY grade, UPDRS motor, HAMA, HAMD, MoCA, ΔSBP, ΔDBP, and UA values, stepwise multiple regression revealed significant correlations between BMI and ΔSBP (p < 0.001), ΔDBP (p = 0.001), MoCA (p = 0.002), UPDRS motor (p = 0.005), and HAMD scores (p = 0.014).

Conclusions

Our study showed that the prevalence of underweight was significantly higher in Chinese newly diagnosed and drug-naïve patients with PD than in the healthy population, and several clinical variables were risk factors for underweight.
Literatur
1.
Zurück zum Zitat Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ (2006) Predictors of weight loss in Parkinson;s disease. Mov Disord 21:930–936CrossRef Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ (2006) Predictors of weight loss in Parkinson;s disease. Mov Disord 21:930–936CrossRef
2.
Zurück zum Zitat Wills AM, Perez A, Wang J, Su X, Morgan J, Rajan SS et al (2016) Association between change in body mass index, unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. JAMA Neurol 73:321–328CrossRef Wills AM, Perez A, Wang J, Su X, Morgan J, Rajan SS et al (2016) Association between change in body mass index, unified Parkinson’s Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. JAMA Neurol 73:321–328CrossRef
3.
Zurück zum Zitat van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR et al (2012) Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267CrossRef van der Marck MA, Dicke HC, Uc EY, Kentin ZH, Borm GF, Bloem BR et al (2012) Body mass index in Parkinson’s disease: a meta-analysis. Parkinsonism Relat Disord 18:263–267CrossRef
4.
Zurück zum Zitat Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson’s disease. Ann Neurol 53:676–679CrossRef Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson’s disease. Ann Neurol 53:676–679CrossRef
5.
Zurück zum Zitat Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983CrossRef Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983CrossRef
6.
Zurück zum Zitat Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM (2007) Body mass index and risk of Parkinson’s disease: a prospective cohort study. Am J Epidemiol 166:1186–1190CrossRef Logroscino G, Sesso HD, Paffenbarger RS Jr, Lee IM (2007) Body mass index and risk of Parkinson’s disease: a prospective cohort study. Am J Epidemiol 166:1186–1190CrossRef
7.
Zurück zum Zitat Umehara T, Nakahara A, Matsuno H, Toyoda C, Oka H (2017) Body weight and dysautonomia in early Parkinson’s disease. Acta Neurol Scand 135:560–567CrossRef Umehara T, Nakahara A, Matsuno H, Toyoda C, Oka H (2017) Body weight and dysautonomia in early Parkinson’s disease. Acta Neurol Scand 135:560–567CrossRef
8.
Zurück zum Zitat Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601CrossRef
9.
Zurück zum Zitat Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699CrossRef
10.
Zurück zum Zitat Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55CrossRef Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32:50–55CrossRef
11.
Zurück zum Zitat Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62CrossRef Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62CrossRef
12.
Zurück zum Zitat Fereshtehnejad SM, Lokk J (2014) Orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism. Park Dis 2014:475854 Fereshtehnejad SM, Lokk J (2014) Orthostatic hypotension in patients with Parkinson’s disease and atypical parkinsonism. Park Dis 2014:475854
13.
Zurück zum Zitat Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy (1996) The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 46:1470CrossRef Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy (1996) The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 46:1470CrossRef
14.
Zurück zum Zitat Sforza M, Assogna F, Rinaldi D, Sette G, Tagliente S, Pontieri FE (2018) Orthostatic hypotension acutely impairs executive functions in Parkinson’s disease. Neurol Sci 39:1459–1462CrossRef Sforza M, Assogna F, Rinaldi D, Sette G, Tagliente S, Pontieri FE (2018) Orthostatic hypotension acutely impairs executive functions in Parkinson’s disease. Neurol Sci 39:1459–1462CrossRef
15.
Zurück zum Zitat Li H, Zong XN, Ji CY, Mi J (2010) Body mass index cut-offs for overweight and obesity in Chinese children and adolescents aged 2 - 18 years. Zhonghua Liu Xing Bing Xue Za Zhi 31:616–620PubMed Li H, Zong XN, Ji CY, Mi J (2010) Body mass index cut-offs for overweight and obesity in Chinese children and adolescents aged 2 - 18 years. Zhonghua Liu Xing Bing Xue Za Zhi 31:616–620PubMed
16.
Zurück zum Zitat Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G et al (2018) Weight loss and malnutrition in patients with Parkinson’s disease: current knowledge and future prospects. Front Aging Neurosci 10:1CrossRef Ma K, Xiong N, Shen Y, Han C, Liu L, Zhang G et al (2018) Weight loss and malnutrition in patients with Parkinson’s disease: current knowledge and future prospects. Front Aging Neurosci 10:1CrossRef
17.
Zurück zum Zitat Wills AM, Li R, Perez A, Ren X, Boyd J (2017) Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort. J Neurol 264:1746–1753CrossRef Wills AM, Li R, Perez A, Ren X, Boyd J (2017) Predictors of weight loss in early treated Parkinson’s disease from the NET-PD LS-1 cohort. J Neurol 264:1746–1753CrossRef
18.
Zurück zum Zitat Seminara RS, Jeet C, Biswas S, Kanwal B, Iftikhar W, Sakibuzzaman M et al (2018) The neurocognitive effects of Ghrelin-induced signaling on the hippocampus: a promising approach to Alzheimer’s disease. Cureus. 10:e3285PubMedPubMedCentral Seminara RS, Jeet C, Biswas S, Kanwal B, Iftikhar W, Sakibuzzaman M et al (2018) The neurocognitive effects of Ghrelin-induced signaling on the hippocampus: a promising approach to Alzheimer’s disease. Cureus. 10:e3285PubMedPubMedCentral
19.
Zurück zum Zitat Fiszer U, Michalowska M, Baranowska B, Wolinska-Witort E, Jeske W, Jethon M et al (2010) Leptin and ghrelin concentrations and weight loss in Parkinson’s disease. Acta Neurol Scand 121:230–236CrossRef Fiszer U, Michalowska M, Baranowska B, Wolinska-Witort E, Jeske W, Jethon M et al (2010) Leptin and ghrelin concentrations and weight loss in Parkinson’s disease. Acta Neurol Scand 121:230–236CrossRef
20.
Zurück zum Zitat Kotagal V, Lineback C, Bohnen NI, Albin RL (2016) Orthostatic hypotension predicts motor decline in early Parkinson disease. Parkinsonism Relat Disord 32:127–129CrossRef Kotagal V, Lineback C, Bohnen NI, Albin RL (2016) Orthostatic hypotension predicts motor decline in early Parkinson disease. Parkinsonism Relat Disord 32:127–129CrossRef
21.
Zurück zum Zitat Nakamura T, Suzuki M, Ueda M, Hirayama M, Katsuno M (2017) Lower body mass index is associated with orthostatic hypotension in Parkinson’s disease. J Neurol Sci 372:14–18CrossRef Nakamura T, Suzuki M, Ueda M, Hirayama M, Katsuno M (2017) Lower body mass index is associated with orthostatic hypotension in Parkinson’s disease. J Neurol Sci 372:14–18CrossRef
22.
Zurück zum Zitat Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H et al (2016) Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disord 31:1417–1421CrossRef Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H et al (2016) Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disord 31:1417–1421CrossRef
23.
Zurück zum Zitat Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F et al (2000) The pressor response to water drinking in humans : a sympathetic reflex? Circulation. 101:504–509CrossRef Jordan J, Shannon JR, Black BK, Ali Y, Farley M, Costa F et al (2000) The pressor response to water drinking in humans : a sympathetic reflex? Circulation. 101:504–509CrossRef
24.
Zurück zum Zitat Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D (1999) A potent pressor response elicited by drinking water. Lancet (London, England) 353:723CrossRef Jordan J, Shannon JR, Grogan E, Biaggioni I, Robertson D (1999) A potent pressor response elicited by drinking water. Lancet (London, England) 353:723CrossRef
25.
Zurück zum Zitat Coimbra S, Brandao Proenca J, Santos-Silva A, Neuparth MJ (2014) Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int 2014:701915CrossRef Coimbra S, Brandao Proenca J, Santos-Silva A, Neuparth MJ (2014) Adiponectin, leptin, and chemerin in elderly patients with type 2 diabetes mellitus: a close linkage with obesity and length of the disease. Biomed Res Int 2014:701915CrossRef
26.
Zurück zum Zitat Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295CrossRef Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR et al (1996) Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334:292–295CrossRef
27.
Zurück zum Zitat Van Den Saffele JK, Goemaere S, De Bacquer D, Kaufman JM (1999) Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? Clin Endocrinol 51:81–88CrossRef Van Den Saffele JK, Goemaere S, De Bacquer D, Kaufman JM (1999) Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? Clin Endocrinol 51:81–88CrossRef
28.
Zurück zum Zitat Mochizuki H, Taniguchi A, Nakazato Y, Ishii N, Ebihara Y, Sugiyama T et al (2016) Increased body mass index associated with autonomic dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 24:129–131CrossRef Mochizuki H, Taniguchi A, Nakazato Y, Ishii N, Ebihara Y, Sugiyama T et al (2016) Increased body mass index associated with autonomic dysfunction in Parkinson’s disease. Parkinsonism Relat Disord 24:129–131CrossRef
29.
Zurück zum Zitat Balestrino R, Baroncini D, Fichera M, Donofrio CA, Franzin A, Mortini P et al (2017) Weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease is influenced by dyskinesias’ reduction and electrodes’ position. Neurol Sci 38:2123–2129CrossRef Balestrino R, Baroncini D, Fichera M, Donofrio CA, Franzin A, Mortini P et al (2017) Weight gain after subthalamic nucleus deep brain stimulation in Parkinson’s disease is influenced by dyskinesias’ reduction and electrodes’ position. Neurol Sci 38:2123–2129CrossRef
30.
Zurück zum Zitat Wise RA (2013) Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry 73:819–826CrossRef Wise RA (2013) Dual roles of dopamine in food and drug seeking: the drive-reward paradox. Biol Psychiatry 73:819–826CrossRef
31.
Zurück zum Zitat Pilhatsch M, Kroemer NB, Schneider C, Ebersbach G, Jost WH, Fuchs G et al (2013) Reduced body mass index in Parkinson’s disease: contribution of comorbid depression. J Nerv Ment Dis 201:76–79CrossRef Pilhatsch M, Kroemer NB, Schneider C, Ebersbach G, Jost WH, Fuchs G et al (2013) Reduced body mass index in Parkinson’s disease: contribution of comorbid depression. J Nerv Ment Dis 201:76–79CrossRef
32.
Zurück zum Zitat Wang G, Wan Y, Cheng Q, Xiao Q, Wang Y, Zhang J et al (2010) Malnutrition and associated factors in Chinese patients with Parkinson’s disease: results from a pilot investigation. Parkinsonism Relat Disord 16:119–123CrossRef Wang G, Wan Y, Cheng Q, Xiao Q, Wang Y, Zhang J et al (2010) Malnutrition and associated factors in Chinese patients with Parkinson’s disease: results from a pilot investigation. Parkinsonism Relat Disord 16:119–123CrossRef
33.
Zurück zum Zitat Sheard JM, Ash S, Silburn PA, Kerr GK (2011) Prevalence of malnutrition in Parkinson’s disease: a systematic review. Nutr Rev 69:520–532CrossRef Sheard JM, Ash S, Silburn PA, Kerr GK (2011) Prevalence of malnutrition in Parkinson’s disease: a systematic review. Nutr Rev 69:520–532CrossRef
Metadaten
Titel
Prevalence, risk factors, and clinical correlations of underweight in Chinese newly diagnosed and drug-naïve patients with Parkinson’s disease
verfasst von
Qing Wu
Ming Yu
Jianfei Fu
Meizhen Liu
Publikationsdatum
29.10.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 3/2021
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04861-0

Weitere Artikel der Ausgabe 3/2021

Neurological Sciences 3/2021 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.